Kai-Uwe Jarr

9PUBLICATIONS
22CO-AUTHORS
NanomaterialsCardiology (incl. cardiovascular diseases)Environmental biogeochemistryMolecular targetsRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 12, 2026
Polyethylene and Polyvinyl Chloride Nanoplastics Accelerate Atherosclerosis Through Distinct Smooth Muscle Cell Phenotypic Transitions.

|May 07, 2026
CD47 Blockade Reprograms the Monocyte-Macrophage Axis to Promote Inflammation Resolution in Atherosclerosis.

|Mar 02, 2026
Microplastics and Nanoplastics: A New Perspective in Cardiovascular Prevention.

Kai-Uwe Jarr, Annette Peters, Nicholas J Leeper

|Sep 09, 2025
The atherosclerosis-cancer axis: the shared immunotherapeutic potential of CBL inhibition.

Kai-Uwe Jarr, Lingfeng Luo, Nicholas J Leeper

|Jul 21, 2025
Computational Modeling Predicts Benefits of Proefferocytic Therapy in Human Atherosclerosis.

Kai-Uwe Jarr, Kaylin C A Palm, Gerard Pasterkamp

|Jun 27, 2025
Smooth muscle cells in atherosclerosis: essential but overlooked translational perspectives.

Pascal Azar, Kai-Uwe Jarr, Delphine Gomez

Pageof 2

Frequent Collaborators

6 joint publications

Nicholas J Leeper

1 joint publications

Pavlos Tsantilas

1 joint publications

Shen Lao

1 joint publications

Anne Eberhard